Commentary on the EMA Reflection Paper on the use of extrapolation in the development of medicines for paediatrics

27Citations
Citations of this article
65Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Adopted guidelines reflect a harmonised European approach to a specific scientific issue and should reflect the most recent scientific knowledge. However, whilst EU regulations are mandatory for all member states and EU directives must be followed by national laws in line with the directive, EMA guidelines do not have legal force and alternative approaches may be taken, but these obviously require more justification. This new series of the BJCP, developed in collaboration with the EMA, aims to address this issue by providing an annotated version of some relevant EMA guidelines and regulatory documents by experts. Hopefully, this will help in promoting their diffusion and in opening a forum for discussion with our readers.

Cite

CITATION STYLE

APA

Ollivier, C., Thomson, A., Manolis, E., Blake, K., Karlsson, K. E., Knibbe, C. A. J., … Hemmings, R. (2019). Commentary on the EMA Reflection Paper on the use of extrapolation in the development of medicines for paediatrics. British Journal of Clinical Pharmacology, 85(4), 659–668. https://doi.org/10.1111/bcp.13883

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free